Guidelines for the Compilation of a Product Dossier for Submission in the Assessment Procedure for New and Multi-Source (Generic) Products Used in the Treatment of Malaria
(11 pages)
Índice de contenido
Ver el documentoSection 1. Details of the product
Ver el documentoSection 2. Regulatory situation in other countries
Abrir esta carpeta y ver su contenidoSection 3. Active pharmaceutical ingredient (s) (API)
Cerrar esta carpetaSection 4. Finished product
Ver el documentoSection 4.1 Formulation
Ver el documentoSection 4.2. Sites of manufacture
Ver el documentoSection 4.3 Manufacturing procedure
Ver el documentoSection 4.4 Specifications for excipients
Ver el documentoSection 4.5 Specifications for the finished product
Ver el documentoSection 4.6 Container/closure system(s) and other packaging
Ver el documentoSection 4.7 Stability testing
Ver el documentoSection 4.8 Container labelling
Ver el documentoSection 4.9 Product information
Ver el documentoSection 4.10 Patient information and package inserts
Ver el documentoSection 4.11 Justification for any differences to the product in the country or countries issuing the submitted WHO-type certificate(s)6
Abrir esta carpeta y ver su contenidoSection 5. Efficacy and safety
 

Section 4.3 Manufacturing procedure

Provide an outline of the manufacturing procedure for the finished product, including packaging.

Provide a copy of the master formula and a copy of a manufacturing record for a real batch.

For sterile products, details of sterilization processes and /or aseptic procedures used must be described.

A statement of the stages of manufacture at which sampling is carried out for in-process control tests, where other data in the documents supporting the application show such tests to be necessary for the quality control of the medicines

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013